Prosecution Insights
Last updated: October 04, 2026

Engine Biosciences Pte. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Engine Biosciences Pte. Ltd. is currently navigating the prosecution of 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is being handled by 1 distinct examiner, which centralizes the current interaction with the patent office. Furthermore, the portfolio's active matters are located within 1 distinct art unit. This indicates a highly focused prosecution effort without the complexity of managing multiple administrative divisions or varying examiner preferences.

The busiest examiner identified for this portfolio is VISHNYAKOVA, ELENA VLADIMIROVNA, who is assigned to 1 pending office action. Since there is only 1 pending action in total, VISHNYAKOVA, ELENA VLADIMIROVNA is responsible for the entirety of the company's current pending workload. This direct relationship between the examiner's pending count and the total portfolio pending count simplifies the communication strategy for the applicant. Practitioners can focus their resources on the specific requirements and historical tendencies of this single examiner within the designated art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VISHNYAKOVA, ELENA VLADIMIROVNA 1 65.8% +51.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17936089 METHODS AND COMPOSITIONS FOR TREATING CANCER VISHNYAKOVA, ELENA VLADIMIROVNA 28d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17936089 METHODS AND COMPOSITIONS FOR TREATING CANCER VISHNYAKOVA, ELENA VLADIMIROVNA 28d overdue

Top Art Units

Art UnitApps
1691 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17936089 METHODS AND COMPOSITIONS FOR TREATING CANCER VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §103§112 Final Rejection 28d overdue Pending Sep 28, 2022

Managing Engine Biosciences Pte. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month